Dr. Reddy's inks pact with Singapore firm Prestige BioPharma to commercialise Trastuzumab biosimilar in select countries

Hyderabad, Dec 9- Prestige BioPharma Ltd, a Singapore-based firm and Dr. Reddy's Laboratories Ltd., on Thursday announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and commercialisation of the former's proposed Trastuzumab biosimilar in select countries in Latin America and Southeast Asia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3GjQwIy
via IFTTT